[摘要]目的 探讨参附注射液对维持性血液透析患者心率变异性的影响。方法 选取2016年10月～2018年6月我院收治的92例行维持性血液透析患者作为研究对象，根據随机数字表法分为对照组和研究组，每组各46例。对照组患者常规行降压、纠正钙磷代谢紊乱、贫血、甲状腺功能亢进等治疗，研究组在对照组基础上给予参附注射液联合治疗。比较两组治疗前后的血压及生化指标水平、心率变异性，心律失常总发生率。结果 治疗前，两组的收缩压(SBP)、舒张压(DBP)、血清肌酐(Scr)、血糖(Glu)、总胆固醇(Chol)、血清尿酸(UA)水平比较，差异无统计学意义(P>0.05)；两组治疗后的SBP和DBP水平低于治疗前，研究组治疗后的SBP和DBP水平低于对照组，差异均有统计学意义(P50 ms的百分比(PNN50)水平均显著高于对照组及治疗前，差异有统计学意义(P0.05). The levels of SBP and DBP in the two groups after treatment were lower than those before treatment， and the levels of SBP and DBP in the research group after treatment were lower than those in the control group， the differences were statistically significant (P 50 ms (PNN50) in the research group were significantly higher than those in the control group and before treatment， the differences were statistically significant (P, 百拇医药(邹东媚 曾梅珍) 第 1 2 3 页 下一页
 百拇医药网 http://www.100md.com/html/paper/1674-4721/2019/10/27.htm